Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-17 6:33 pm Unchanged | 2025-12-31 | 13G | VistaGen Therapeutics, Inc. VTGN | ORBIMED ADVISORS LLC | 1,639,700 4.200% | 0 (Unchanged) | Filing History |
| 2026-02-17 4:26 pm Purchase | 2025-12-31 | 13G | VistaGen Therapeutics, Inc. VTGN | Commodore Capital LP | 4,383,508 9.900% | 2,015,624 (+85.12%) | Filing History |
| 2026-02-17 4:16 pm Unchanged | 2025-12-31 | 13G | VistaGen Therapeutics, Inc. VTGN | Great Point Partners, LLC | 2,055,834 4.950% | 0 (Unchanged) | Filing History |
| 2026-02-17 12:35 pm Sale | 2025-12-31 | 13G | VistaGen Therapeutics, Inc. VTGN | JANUS HENDERSON GROUP PLC JHG | 0 0.000% | -4,165,767 (Position Closed) | Filing History |
| 2026-02-17 10:02 am Sale | 2025-12-31 | 13G | VistaGen Therapeutics, Inc. VTGN | StemPoint Capital LP | 616,749 1.500% | -1,711,743 (-73.51%) | Filing History |
| 2026-02-13 5:08 pm Sale | 2025-12-31 | 13G | VistaGen Therapeutics, Inc. VTGN | Nantahala Capital Management, LLC | 1,953,045 4.710% | -1,232,519 (-38.69%) | Filing History |
| 2026-01-30 2:47 pm Purchase | 2025-12-31 | 13G | VistaGen Therapeutics, Inc. VTGN | The Vanguard Group | 1,824,738 4.620% | 137,003 (+8.12%) | Filing History |
| 2025-11-14 6:04 pm Purchase | 2025-09-30 | 13G | VistaGen Therapeutics, Inc. VTGN | ORBIMED ADVISORS LLC | 1,639,700 5.340% | 1,639,700 (New Position) | Filing History |
| 2025-11-14 4:37 pm Purchase | 2025-09-30 | 13G | VistaGen Therapeutics, Inc. VTGN | Nantahala Capital Management, LLC | 3,185,564 9.990% | 351,228 (+12.39%) | Filing History |
| 2025-11-14 3:18 pm Unchanged | 2025-09-30 | 13G | VistaGen Therapeutics, Inc. VTGN | Great Point Partners, LLC | 2,055,834 6.280% | 0 (Unchanged) | Filing History |
| 2025-10-31 11:41 am Sale | 2025-09-30 | 13G | VistaGen Therapeutics, Inc. VTGN | The Vanguard Group | 1,687,735 5.500% | -146,777 (-8.00%) | Filing History |
| 2025-09-08 1:07 pm Purchase | 2025-08-29 | 13G | VistaGen Therapeutics, Inc. VTGN | JANUS HENDERSON GROUP PLC JHG | 4,165,767 13.600% | 4,165,767 (New Position) | Filing History |
| 2025-08-14 5:13 pm Unchanged | 2025-06-30 | 13G | VistaGen Therapeutics, Inc. VTGN | Great Point Partners, LLC | 2,055,834 6.590% | 0 (Unchanged) | Filing History |
| 2025-05-15 4:48 pm Unchanged | 2025-03-31 | 13G | VistaGen Therapeutics, Inc. VTGN | Great Point Partners, LLC | 2,055,834 6.650% | 0 (Unchanged) | Filing History |
| 2025-02-14 4:40 pm Sale | 2024-12-31 | 13G | VistaGen Therapeutics, Inc. VTGN | Great Point Partners, LLC | 2,055,834 6.880% | -674,075 (-24.69%) | Filing History |
| 2025-02-14 4:28 pm Purchase | 2024-12-31 | 13G | VistaGen Therapeutics, Inc. VTGN | BIOTECHNOLOGY VALUE FUND L P | 3,084,324 9.970% | 307,079 (+11.06%) | Filing History |
| 2025-02-14 1:01 pm Purchase | 2024-12-31 | 13G | VistaGen Therapeutics, Inc. VTGN | StemPoint Capital LP | 2,328,492 8.200% | 538,310 (+30.07%) | Filing History |
| 2024-11-14 5:05 pm Sale | 2024-09-30 | 13G | VistaGen Therapeutics, Inc. VTGN | Great Point Partners, LLC | 2,729,909 9.380% | -63,018 (-2.26%) | Filing History |
| 2024-11-14 4:53 pm Purchase | 2024-09-30 | 13G | VistaGen Therapeutics, Inc. VTGN | Nantahala Capital Management, LLC | 2,834,336 9.990% | 36,748 (+1.31%) | Filing History |
| 2024-11-14 4:19 pm Sale | 2024-09-30 | 13G | VistaGen Therapeutics, Inc. VTGN | Citadel Advisors LLC | 1,158,219 4.200% | -442,549 (-27.65%) | Filing History |